The present invention provides compositions and methods for inducing tolerancein a human. The invention includesadministering a genetically modified T cell expressing a CAR wherein the CARcomprises an antigen binding domain, a transmembranedomain, a costimulatory signaling region, and a CD3 zeta signaling domain.